SUMOylation is a significant regulatory posttranslational modification, and its covalent bond interaction with NSUN2 to form the SUMOylation–NSUN2–m5C axis is a novel mechanism and therapeutic target for gastric cancer cells.368. The gene discussed is NSUN2; the disease is gastric cancer.